Clarivate Epidemiology’s coverage of malignant melanoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
Clarivate Epidemiology’s coverage of malignant melanoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology’s coverage of pemphigus vulgaris comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany,…
Clarivate Epidemiology’s coverage of polycystic kidney disease comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France…
DRG Epidemiology’s coverage of tuberous sclerosis comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…
Clarivate Epidemiology’s coverage of amyotrophic lateral sclerosis (ALS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United…
Clarivate Epidemiology’s coverage of generalized anxiety disorder (GAD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (United States,…
Clarivate’s Epidemiology’s coverage of GIST comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of GIST for each country, as…
DRG Epidemiology’s coverage of progressive supranuclear palsy (PSP) comprises epidemiological estimates of diagnosed prevalence across the major mature pharmaceutical markets (the United States…
DRG Epidemiology’s coverage of social anxiety disorder (SAD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
DRG Epidemiology’s coverage of Essential Thrombocythemia comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
DRG Epidemiology’s coverage of polycythemia vera comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…
DRG Epidemiology’s coverage of traumatic brain injury (TBI) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (United States, France,…
We reviewed the published literature, including online registries and surveys, using a systematic search with a defined date range, for the most representative epidemiological data on uterine…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key Coronary Heart Disease patient populations covering 171 countries…